表纸
市场调查报告书

全球止血剂·组织密封胶市场:2020年~2024年的预测

Global Hemostats and Tissue Sealants Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品编码 361449
出版日期 内容资讯 英文 157 Pages
订单完成后即时交付
价格
全球止血剂·组织密封胶市场:2020年~2024年的预测 Global Hemostats and Tissue Sealants Market 2020-2024
出版日期: 2020年01月02日内容资讯: 英文 157 Pages
简介

全球止血剂·组织密封胶市场在预测期间内预计将以5%的年复合成长率增长,2024年达到9亿2,195万美元的规模。市场成长的主要因素有手术中使用止血剂和组织密封剂。此外新型止血药和组织密封剂的研发不断增加,也有望推动市场增长。

本报告提供全球止血剂·组织密封胶市场的相关调查,提供市场成长要素,趋势和课题,产品·各地区的市场分析,业者情势,主要企业的简介等资讯。

目录

第1章 摘要整理

第2章 报告的范围

  • 序文
  • 美金的汇率

第3章 市场情形

  • 市场生态系统
  • 市场特征
  • 市场区隔分析
  • 价值链分析

第4章 市场规模

  • 市场定义
  • 2019年的市场规模
  • 市场预测
  • 市场规模与预测:2019-2024

第5章 波特的五力分析

  • 买主谈判力
  • 供应商谈判力
  • 新加入厂商的威胁
  • 替代品的威胁
  • 对手的威胁
  • 市场情况

第6章 市场分析:各产品

  • 市场区隔
  • 比较
  • 止血剂
  • 组织密封胶·黏剂
  • 纤维蛋白胶
  • 市场机会

第7章 客户形势

第8章 市场分析:各地区

  • 市场区隔
  • 比较
  • 北美
  • 欧洲
  • 亚洲
  • 其他地区
  • 主要国家
  • 市场机会

第9章 思考架构

第10章 成长要素与课题

  • 市场成长要素
  • 市场课题

第11章 市场趋势

  • 策略性的合作·收购
  • 研发专注于新型止血剂和组织密封剂
  • 新兴国家的高增长潜力

第12章 业者情势

  • 概要
  • 形势的创新
  • 竞争模式

第13章 企业简介

  • 交易厂商
  • 供应商分类
  • 供应商的市场定位
  • Advanced Medical Solutions Group Plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Co.
  • CryoLife Inc.
  • Integra LifeSciences Holdings Corp.
  • Johnson & Johnson Services Inc.
  • Medtronic Plc
  • Pfizer Inc.
  • Teleflex Inc.

第14章 附录

  • 调查方法
  • 简称的清单
  • 供应商的市场定位定义

第15章 关于TECHNAVIO

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: IRTNTR40802

Technavio has been monitoring the global hemostats and tissue sealants market and it is poised to grow by USD 921.95 mn during 2020-2024, progressing at a CAGR of 5% during the forecast period. Our reports on global hemostats and tissue sealants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by use of hemostats and tissue sealants in surgeries.In addition, increasing r&d on novel hemostats and tissue sealants is anticipated to boost the growth of the global hemostats and tissue sealants market as well.

Market Segmentation

Technavio's global hemostats and tissue sealants market is segmented as below:

Product:

  • Hemostats
  • Tissue Sealants And Adhesives
  • Fibrin Sealants

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global hemostats and tissue sealants market growth

This study identifies increasing r&d on novel hemostats and tissue sealants as the prime reasons driving the global hemostats and tissue sealants market growth during the next few years.

Prominent vendors in global hemostats and tissue sealants market

We provide a detailed analysis of around 25 vendors operating in the global hemostats and tissue sealants market , including some of the vendors such as Advanced Medical Solutions Group Plc, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CryoLife Inc., Integra LifeSciences Holdings Corp., Johnson & Johnson Services Inc., Medtronic Plc, Pfizer Inc. and Teleflex Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market Outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Hemostats - Market size and forecast 2019-2024
  • Tissue sealants and adhesives - Market size and forecast 2019-2024
  • Fibrin sealants - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Strategic collaborations and acquisitions
  • Increasing R&D focus on novel hemostats and tissue sealants
  • High growth potential in emerging countries

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Advanced Medical Solutions Group Plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Co.
  • CryoLife Inc.
  • Integra LifeSciences Holdings Corp.
  • Johnson & Johnson Services Inc.
  • Medtronic Plc
  • Pfizer Inc.
  • Teleflex Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare equipment market
  • Exhibit 02: Segments of global healthcare equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Hemostats - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Hemostats - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Tissue sealants and adhesives - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Tissue sealants and adhesives - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Fibrin sealants - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Fibrin sealants - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Market opportunity by product
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2019-2024 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Increase in the number of various laparoscopic surgical procedures in European countries
  • Exhibit 33: Number of people aged 65 years and above in EU and countries in 2005 and 2018 (in millions)
  • Exhibit 34: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
  • Exhibit 37: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 38: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 39: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 40: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 41: Key leading countries
  • Exhibit 42: Market opportunity
  • Exhibit 43: Impact of drivers and challenges
  • Exhibit 44: Vendor landscape
  • Exhibit 45: Landscape disruption
  • Exhibit 46: Vendors covered
  • Exhibit 47: Vendor classification
  • Exhibit 48: Market positioning of vendors
  • Exhibit 49: Advanced Medical Solutions Group Plc - Vendor overview
  • Exhibit 50: Advanced Medical Solutions Group Plc - Business segments
  • Exhibit 51: Advanced Medical Solutions Group Plc - Organizational developments
  • Exhibit 52: Advanced Medical Solutions Group Plc - Geographic focus
  • Exhibit 53: Advanced Medical Solutions Group Plc - Segment focus
  • Exhibit 54: Advanced Medical Solutions Group Plc - Key offerings
  • Exhibit 55: B. Braun Melsungen AG - Vendor overview
  • Exhibit 56: B. Braun Melsungen AG - Business segments
  • Exhibit 57: B. Braun Melsungen AG - Organizational developments
  • Exhibit 58: B. Braun Melsungen AG - Geographic focus
  • Exhibit 59: B. Braun Melsungen AG - Segment focus
  • Exhibit 60: B. Braun Melsungen AG - Key offerings
  • Exhibit 61: Baxter International Inc. - Vendor overview
  • Exhibit 62: Baxter International Inc. - Business segments
  • Exhibit 63: Baxter International Inc. - Organizational developments
  • Exhibit 64: Baxter International Inc. - Geographic focus
  • Exhibit 65: Baxter International Inc. - Segment focus
  • Exhibit 66: Baxter International Inc. - Key offerings
  • Exhibit 67: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 68: Becton, Dickinson and Co. - Business segments
  • Exhibit 69: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 70: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 71: Becton, Dickinson and Co. - Segment focus
  • Exhibit 72: Becton, Dickinson and Co. - Key offerings
  • Exhibit 73: CryoLife Inc. - Vendor overview
  • Exhibit 74: CryoLife Inc. - Business segments
  • Exhibit 75: CryoLife Inc. - Organizational developments
  • Exhibit 76: CryoLife Inc. - Geographic focus
  • Exhibit 77: CryoLife Inc. - Segment focus
  • Exhibit 78: CryoLife Inc. - Key offerings
  • Exhibit 79: Integra LifeSciences Holdings Corp. - Vendor overview
  • Exhibit 80: Integra LifeSciences Holdings Corp. - Business segments
  • Exhibit 81: Integra LifeSciences Holdings Corp. - Organizational developments
  • Exhibit 82: Integra LifeSciences Holdings Corp. - Geographic focus
  • Exhibit 83: Integra LifeSciences Holdings Corp. - Segment focus
  • Exhibit 84: Integra LifeSciences Holdings Corp. - Key offerings
  • Exhibit 85: Johnson & Johnson Services, Inc. - Vendor overview
  • Exhibit 86: Johnson & Johnson Services, Inc. - Business segments
  • Exhibit 87: Johnson & Johnson Services, Inc. - Organizational developments
  • Exhibit 88: Johnson & Johnson Services, Inc. - Geographic focus
  • Exhibit 89: Johnson & Johnson Services, Inc. - Segment focus
  • Exhibit 90: Johnson & Johnson Services, Inc. - Key offerings
  • Exhibit 91: Medtronic Plc - Vendor overview
  • Exhibit 92: Medtronic Plc - Business segments
  • Exhibit 93: Medtronic Plc - Organizational developments
  • Exhibit 94: Medtronic Plc - Geographic focus
  • Exhibit 95: Medtronic Plc - Segment focus
  • Exhibit 96: Medtronic Plc - Key offerings
  • Exhibit 97: Pfizer Inc. - Vendor overview
  • Exhibit 98: Pfizer Inc. - Business segments
  • Exhibit 99: Pfizer Inc. - Organizational developments
  • Exhibit 100: Pfizer Inc. - Geographic focus
  • Exhibit 101: Pfizer Inc. - Segment focus
  • Exhibit 102: Pfizer Inc. - Key offerings
  • Exhibit 103: Teleflex Inc. - Vendor overview
  • Exhibit 104: Teleflex Inc. - Business segments
  • Exhibit 105: Teleflex Inc. - Organizational developments
  • Exhibit 106: Teleflex Inc. - Geographic focus
  • Exhibit 107: Teleflex Inc. - Segment focus
  • Exhibit 108: Teleflex Inc. - Key offerings
  • Exhibit 109: Validation techniques employed for market sizing
  • Exhibit 110: Definition of market positioning of vendors